A simple urine test can more than halve the number of cystoscopies necessary to follow up high-risk bladder cancer patients, new research has found. Cystoscopies involve inserting a flexible probe ...

In a new study, researchers found that cystoscopy, the standard for screening for recurrence of early-stage bladder cancer, is a cost-effective method of detecting tumors. Adding other tests to ...

Clinical study launched in June 2022 with patient recruitment in Alberta with plans to expand to further sites across North America. The aim of the study is to validate a novel and minimally invasive ...

A range of other assessments besides the bladder pressure test work just as well in guiding treatment of female incontinence, researchers reported Saturday in The Lancet. Adobe stock/HealthDay A small ...

A urine test that detects proteins given off by malignant growths can identify bladder cancer faster and perhaps reduce the use of more invasive procedures, researchers said Tuesday. The $30 test that ...

March 10 (UPI) --Identifying genetic mutations in urine could help detect bladder cancer years before symptoms arise, a new study presented Friday at the European Association of Urology annual ...

Researchers have developed a test for urine, gathered during a routine procedure, to detect DNA mutations identified with urothelial cancers. Researchers at The Johns Hopkins Kimmel Cancer Center have ...

A simple and cost-effective urine test could improve early detection and management of bladder cancer, according to a brief issued by the International Agency for Research on Cancer (IARC). This test ...

A specialized urine test can detect bladder cancer by as much as three to six months earlier than an invasive cystoscopy procedure. Specialists at Skyline Urology, based in Los Angeles, Ca, USA, are ...

A simple urine test for genetic mutations in urine-derived DNA can predict urothelial cancer up to 12 years before patients develop symptoms, an international team of researchers claims. The test, if ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte, Inc., (Nasdaq: VCYT) announced today the publication of new data demonstrating that the company’s Decipher Bladder genomic classifier accurately ...